Plaintiff
Defendant
- Parties: The plaintiffs were Amgen Canada Inc. and Onyx Therapeutics Inc. The defendant was Glenmark Pharmaceuticals Canada Inc.
- Subject Matter: This action involved the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133. This case is ongoing.
- Date: The hearing was set on Nov. 8, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-2585-24Practice Area
Intellectual propertyAmount
$ 0Winner
Trial Start Date
04 October 2024Download documents